Title:
The constituent used for easing the condition which accompanies premenstrual syndrome, and unpleasant-before menses mood disorders
Document Type and Number:
Japanese Patent JP5963791
Kind Code:
B2
Abstract:
The present invention discloses pharmaceutical/nutritional compositions for use in alleviating symptoms associated with premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). The pharmaceutical/nutritional compositions include at least 2% (w/w) phosphatidyl-L-serine, or salts thereof, out of a total effective composition, as a first effective ingredient; and a suitable amount of at least one bio-available form of magnesium as a second effective ingredient. Preferably, the bio-available form of magnesium is magnesium oxide, magnesium citrate, magnesium hydroxide, magnesium stearate, or a magnesium salt of the phosphatidyl-L-serine. Preferably, the composition further includes a pharmaceutical or nutritional excipient. Preferably, the total effective composition is administrable in a multi-part regimen. Preferably, the total effective composition is administrable by intravenous or oral delivery. Preferably, the pharmaceutical/nutritional composition further includes at least 2% (w/w) phosphatidic acid, or salts thereof, out of the total effective composition, as a first effective ingredient.
Inventors:
David Rutenberg
Lina Perry Fayerberger
Lina Perry Fayerberger
Application Number:
JP2014029125A
Publication Date:
August 03, 2016
Filing Date:
February 19, 2014
Export Citation:
Assignee:
Lipogen Eltidi.
International Classes:
A61K33/06; A23L33/115; A23L33/16; A61K31/661; A61K33/08; A61P5/24; A61P15/08; A61P25/24; A61P43/00
Domestic Patent References:
| JP201193881A |
Foreign References:
| EP1661575A1 | ||||
| EP1201244A2 |
Attorney, Agent or Firm:
Einzel Felix-Reinhard
Takuya Kuno
Kamiya Yukie
Hirofumi Mimata
Takuya Kuno
Kamiya Yukie
Hirofumi Mimata